Regeneron (REGN) returns

Biotechnology · NASDAQ · Health Care

$927.89 +13.33% Close Oct 30, 2026 Live

Regeneron returns over 10 years

$1,000 invested in Regeneron ten years ago was worth $2,632 at the close on October 30, 2026, with dividends reinvested: an average return of 10.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

REGN, $10,000 investedS&P 500 (SPY)
$10,000$20,000$30,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +22.4% — $1,224 -0.9%
3 months +25.8% — $1,258 +2.1%
Year to date +20.7% — $1,207 +11.7%
1 year +42.6% — $1,426 +12.4%
3 years +20.4% +6.4% $1,204 +88.5%
5 years +46.3% +7.9% $1,463 +76.0%
10 years +163.2% +10.2% $2,632 +316.6%

Regeneron return by calendar year

YearREGNS&P 500 (SPY)Difference
2026 to date +20.7% +11.7% +9.0%
2025 +8.9% +17.7% -8.8%
2024 -18.9% +24.9% -43.8%
2023 +21.7% +26.2% -4.5%
2022 +14.2% -18.2% +32.4%
2021 +30.7% +28.7% +2.0%
2020 +28.7% +18.4% +10.3%
2019 +0.5% +31.2% -30.7%
2018 -0.7% -4.6% +3.9%
2017 +2.4% +21.7% -19.3%
2016 -32.4% +12.0% -44.4%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: REGN financials · REGN valuation

No forecast, no recommendation. This page describes Regeneron from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.